Health
Novavax Inks Vaccine Deals In Japan, India; Analyst Sees 70% Stock Upside – Gooruf
As part of the partnership, Novavax ( NVAX ) will license COVID-19 vaccine technology to Takeda for local production and commercialization in Japan. In exchange, Novavax will receive payments based on the achievement of certain development and commercial mile…
Article summary
As part of the partnership, Novavax ( NVAX ) will license COVID-19 vaccine technology to Takeda for local production and commercialization in Japan. In exchange, Novavax will receive payments based on the achievement of certain development and commercial milestones, as well as a portion of vaccine proceeds….
-
Noosa News21 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News22 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business24 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
General20 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands